IndraLab

Statements

BCL2 activates USP9X. 1 / 1

| 1

reach

"Treatment with TIC10 and ONC201 and concomitant inhibition of Bcl-2 and Bcl-xL depletes the Mcl-1 chaperone Bag3 and the deubiquitinase Usp9X."

26474387

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

BCL2 activates USP9X. 1 / 1

INDRA sources:

Databases

Reading